Exploring how sleep and activity information can support patients, carers, family members and clinical teams during inpatient stays on mental health wards

ISRCTN ISRCTN11737321
DOI https://doi.org/10.1186/ISRCTN11737321
IRAS number 337784
Secondary identifying numbers IRAS 337784, CPMS 60339
Submission date
11/01/2024
Registration date
02/07/2024
Last edited
02/08/2024
Recruitment status
No longer recruiting
Overall study status
Ongoing
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Although there are links between sleep and mental health, it is difficult to measure someone’s sleep without disturbing them. This study will explore whether prototype contact-free sleep measurement software, and contact-free activity metrics, can be useful to patients, their carers and family members, and clinicians in understanding patterns of sleep and activity during inpatient mental health care.

Who can participate?
People aged 18 years or older can take part if they are adult patients on an inpatient mental health ward where a contact-free monitoring system is already used as part of routine care. They will only be approached about the study if they have capacity to decide whether to take part and if their care team feel that taking part in the study will have no negative effects for the patient.

What does the study involve?
If a patient gives written informed consent to take part in the study, data from their stay in the hospital will be processed by new software to generate prototype reports showing patterns of sleep and activity. These prototype reports will be shown to the patient so that they can give feedback on the reports and whether or not they would find them useful (for example in understanding how their sleep patterns may change during a stay in hospital).
The patient can choose whether the reports are shown to one of their carers or family members, to ask for their feedback.
The reports will also be shown to the clinical team on the ward to gather their feedback.
The patient will leave the study at the end of their stay on the ward, or they can choose to leave the study any time before then.

What are the possible benefits and risks of participating?
There are no direct benefits of taking part in the study, although patients may find it interesting to give their feedback on the prototype reports. The study is designed to have no effect on the patient’s usual care (such as the patient’s treatment, routine usage of the contact-free monitoring system by staff, or how long the patient stays in hospital).

Where is the study run from?
University of Liverpool (UK)

When is the study starting and how long is it expected to run for?
October 2023 to August 2025

Who is funding the study?
Oxehealth Limited (UK)

Who is the main contact?
Prof. Dan Joyce, d.joyce@liverpool.ac.uk

Contact information

Prof Dan Joyce
Public, Scientific, Principal Investigator

Department of Primary Care and Mental Health
B122, Waterhouse Building, Block B
Institute of Population Health
University of Liverpool
Liverpool
L69 3GF
United Kingdom

ORCiD logoORCID ID 0000-0002-9433-5340
Phone +44 (0)1517950139
Email d.joyce@liverpool.ac.uk

Study information

Study designExploratory cohort observational study
Primary study designObservational
Secondary study designCohort study
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, available at study sites
Scientific titleSleep and activity patterns to support mental health inpatient care
Study acronymSAP
Study objectivesThis study will investigate whether prototype contact free sleep and activity reports might be useful to support patients, their carers or family members, and clinicians in inpatient settings. It will also explore the relationships between patterns of sleep and activity and psychiatric conditions.
Ethics approval(s)

Approved 09/04/2024, South Central - Oxford C Research Ethics Committee (Health Research Authority, 2 Redman Place, Stratford, London, E20 1JQ, United Kingdom; +44 (0)207 104 8271; oxfordc.rec@hra.nhs.uk), ref: 24/SC/0055

Health condition(s) or problem(s) studiedInpatient mental health
InterventionPatients on mental health inpatient wards will be approached about the study, with the permission of their care team and if they have capacity to decide whether to take part. If a patient gives written informed consent to take part in the study, prototype sleep and activity reports will be generated for the period of their stay on the ward. The patient will be asked to give feedback on the prototype reports. With the patient's permission, a carer or family member may also be approached about the study and, if they give written informed consent, asked for feedback on the prototype reports. The clinical team on the ward will also be asked for feedback on the prototype reports.
Intervention typeOther
Primary outcome measureThe utility of prototype sleep and activity reports for patients, their carers and clinicians is measured using semi-structured interviews to gather qualitative data. Each participant will undertake one interview towards the end of their participation in the study. The outcome will be measured by identifying and summarising key themes from the interview responses.
Secondary outcome measures1. Patterns of sleep and activity measured by processing anonymised data for the duration of their stay on the ward, when written informed consent to participate is provided by a patient.
2. Patient diagnoses, symptoms, treatment or stage of recovery measured by extracting anonymised information from the patient records, for the duration of their stay on the ward, when written informed consent to participate has been given. As part of standard care, these data are recorded in the patient records whenever new information is gathered by the care team.
3. Occurrences of sleep disturbance on the ward (such as night-time visits by staff conducting periodic observations) measured using the sleep and activity data generated by processing anonymised data as above for the duration of the patient’s stay on the ward, to be measured at the time of discharge.
Overall study start date01/10/2023
Completion date31/08/2025

Eligibility

Participant type(s)Health professional, Carer, Service user
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants150
Key inclusion criteria1. Adult (aged 18 years or older)
2. Currently an inpatient on a ward where the Oxevision system is already in routine clinical use
3. The Oxevision system has been used during their routine care (dependent on Trust policies)
4. Able to understand the study (patient information sheets and informed consent process)
5. Has the capacity to make an informed decision about whether to take part and to decide whether to withdraw consent at any later stage
6. Able to give written informed consent if they wish to take part
Key exclusion criteria1. On the basis of clinical expert opinion of the multidisciplinary team, being approached and/or taking part in the study might cause additional anxiety or distress to the patient or be unhelpful to their recovery
Date of first enrolment29/07/2024
Date of final enrolment15/04/2025

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Central and North West London NHS Foundation Trust
Trust Headquarters
350 Euston Road
Regents PLACE
London
NW1 3AX
United Kingdom

Sponsor information

Oxehealth Limited
Industry

Magdalen Centre
Oxford Science Park
Oxford
OX4 4GA
England
United Kingdom

Phone +44 (0)1865900599
Email oliver.gibson@oxehealth.com
Website http://www.oxehealth.com

Funders

Funder type

Industry

Oxehealth Limited

No information available

Results and Publications

Intention to publish date31/12/2025
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot expected to be made available
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal and presentation at conferences.
IPD sharing planThe datasets generated during and/or analysed during the current study are not expected to be made available to ensure that the confidentiality of participants is maintained.

Editorial Notes

02/08/2024: Internal review.
25/03/2024: Study's existence confirmed by the Oxehealth Limited.